Brazilian trials approved: RESEARCH PROJECT DAT
Post# of 148169
(Total Views: 1135)
Posted On: 06/15/2021 2:01:06 PM
Brazilian trials approved:
RESEARCH PROJECT DATA
Public Title: A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Leronlimab in combination with standard treatment for hospitalized patients with coronavirus pneumonia 2019 (COVID-19 who do not require mechanical ventilation or extracorporeal membrane oxygenation.
PI: REMO NETHERLANDS OF MENDONCA FURTADO
Public Contact: STOLEN MENDONCA NETHERLANDS REMO
Health conditions or problems studied: COVID19
Pneumonia
ICD Descriptors - General: COVID-19, virus identified
ICD Descriptors - Specific: COVID-19, virus identified
ICD - Intervention Descriptors: COVID-19, virus identified
CEP/CONEP Ethics Approval Date: 06/15/2021
DATA FROM THE PROPOSING INSTITUTION
Institution Name: BENEF ISRAELITABRAS HOSPITAL ALBERT EINSTEIN COMPANY
City: SÃO PAULO
DATA OF THE RESEARCH ETHICS COMMITTEE
Responsible Ethics Committee: 71 - Hospital Israelita Albert Einstein-SP
Address: Av. Albert Einstein 627 - 2ss
Phone: (11)2151-3729
E-mail: cep@einstein.br
RESEARCH PROJECT PARTICIPANT CENTRE(S)
RESEARCH PROJECT CO-PARTICIPANT CENTER(S)
https://plataformabrasil.saude.gov.br/login.jsf
RESEARCH PROJECT DATA
Public Title: A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Leronlimab in combination with standard treatment for hospitalized patients with coronavirus pneumonia 2019 (COVID-19 who do not require mechanical ventilation or extracorporeal membrane oxygenation.
PI: REMO NETHERLANDS OF MENDONCA FURTADO
Public Contact: STOLEN MENDONCA NETHERLANDS REMO
Health conditions or problems studied: COVID19
Pneumonia
ICD Descriptors - General: COVID-19, virus identified
ICD Descriptors - Specific: COVID-19, virus identified
ICD - Intervention Descriptors: COVID-19, virus identified
CEP/CONEP Ethics Approval Date: 06/15/2021
DATA FROM THE PROPOSING INSTITUTION
Institution Name: BENEF ISRAELITABRAS HOSPITAL ALBERT EINSTEIN COMPANY
City: SÃO PAULO
DATA OF THE RESEARCH ETHICS COMMITTEE
Responsible Ethics Committee: 71 - Hospital Israelita Albert Einstein-SP
Address: Av. Albert Einstein 627 - 2ss
Phone: (11)2151-3729
E-mail: cep@einstein.br
RESEARCH PROJECT PARTICIPANT CENTRE(S)
RESEARCH PROJECT CO-PARTICIPANT CENTER(S)
https://plataformabrasil.saude.gov.br/login.jsf
(23)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼